Royal Bank of Canada
NVNO

Royal Bank of Canada’s enVVeno Medical NVNO Stock Holding History

Royal Bank of Canada’s Portfolio NVNO Stock Details NVNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-43
Closed -$5K – 7133
2024
Q3 		$5K Buy
43
+40
+1,333% +$7.35K ﹤0.01% 6507
2024
Q2 		$1K Buy
+3
New +$524 ﹤0.01% 6865
2024
Q1 		– Sell
-3
Closed -$538 – 7409
2023
Q4 		$1K Buy
3
+2
+200% +$318 ﹤0.01% 6956
2023
Q3 		$0 Sell
1
-2
-67% -$334 ﹤0.01% 7412
2023
Q2 		$0 Buy
+3
New +$390 ﹤0.01% 7526
2022
Q4 		– Sell
-2
Closed – – 7563
2022
Q3 		$0 Buy
+2
New +$426 ﹤0.01% 7714

Other funds holding NVNO

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada's NVNO Position: Q4 2024 in Review

Royal Bank of Canada sold out of enVVeno Medical (NVNO) in Q4 2024, closing a stake of 43 shares — an estimated $5K sold.

Royal Bank of Canada first reported a position in NVNO in Q3 2022 and held it in 6 quarters. The position peaked at $5K in Q3 2024. 34 funds tracked by Wall St. Rank hold NVNO as of Q4 2024.

  • Royal Bank of Canada reported no remaining enVVeno Medical position as of Q4 2024 after selling out during the quarter.
  • Royal Bank of Canada sold 43 enVVeno Medical shares in Q4 2024, an estimated $5K.
  • Royal Bank of Canada first reported a position in enVVeno Medical in Q3 2022 and held it in 6 quarters.
  • Royal Bank of Canada's enVVeno Medical position peaked at $5K in Q3 2024.
  • 34 funds tracked by Wall St. Rank held enVVeno Medical as of Q4 2024.

Based on Royal Bank of Canada's 13F filing for Q4 2024, filed 14 Feb 2025.